Last updated on July 2019

Entyvio (Vedolizumab) Long Term Safety Study


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Ulcerative Colitis and Crohn's Disease
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Signed informed consent, by the participant or a legally acceptable representative.
  2. Aged at least 18 years.
  3. Initiating vedolizumab or another biologic agent for UC or CD.
  4. Signed release form, by the participant or a legally acceptable representative, permitting abstraction of the participant's medical records at Baseline and during participation in the study.

Exclusion Criteria:

  1. The participant is enrolled in a clinical trial in which treatment for CD or UC is managed through a protocol.
  2. Prior treatment with vedolizumab.
  3. Any other reason that, in the Investigator's opinion, makes the participant unsuitable to participate in this study.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.